Novel genetic and epigenetic alterations in ... - Ous-research.no
Novel genetic and epigenetic alterations in ... - Ous-research.no
Novel genetic and epigenetic alterations in ... - Ous-research.no
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
had mutation frequencies of 75% or higher <strong>in</strong> both series. TAF1B is an essential part of theRNA polymerase I cofactor SL1, which is important for transcriptional <strong>in</strong>itiation <strong>in</strong> general,as it is <strong>in</strong>volved <strong>in</strong> the b<strong>in</strong>d<strong>in</strong>g of regulatory prote<strong>in</strong>s at the TATA-box.[27;28] Its comutatedgene, ACVR2A (activ<strong>in</strong> receptor 2), transmits the growth <strong>in</strong>hibitory effects ofactiv<strong>in</strong> via phosphorylation of SMAD prote<strong>in</strong>s to affect gene transcription through theTGF signal<strong>in</strong>g pathway.[29] Activ<strong>in</strong> has been shown to regulate differentiation,proliferation <strong>and</strong> apoptosis <strong>in</strong> several cancer types.[29] When both these genes are<strong>in</strong>activated <strong>in</strong> a tumor, it provides severe deregulation of transcription as a whole as well asloss of the growth <strong>in</strong>hibitory effects of activ<strong>in</strong>,[29] strategies which are positive for a tumorcell.MRE11A is <strong>in</strong>volved <strong>in</strong> double str<strong>and</strong> DNA break repair along with several other prote<strong>in</strong>s<strong>and</strong> is clearly important <strong>in</strong> ma<strong>in</strong>ta<strong>in</strong><strong>in</strong>g high DNA fidelity.[30] The role of ASTE1(previously k<strong>no</strong>wn as HT001) is <strong>no</strong>t k<strong>no</strong>wn, so any mutational consequences of this generema<strong>in</strong> to be resolved. Hence, the impact of the loss of both these genes <strong>in</strong> a tumor cell thusrema<strong>in</strong>s elusive. A<strong>no</strong>ther possibility is that the recognized correlations are merely due to highmutation rates rather than important biological functions.MSI-L tumors are usually ack<strong>no</strong>wledged to have a phe<strong>no</strong>type analogous to MSS.[6;31] Asexpected, we saw a significant difference <strong>in</strong> mutation frequencies between tumors with ahigh <strong>and</strong> low degree of microsatellite <strong>in</strong>stability as the MSI-L tumors harbored a mean ofone mutation per tumor. This <strong>in</strong>dicates that MSI-L is <strong>in</strong>sufficient to <strong>in</strong>duce the mutatorphe<strong>no</strong>type <strong>in</strong> CRC.20